Structural Studies of the Taurine Transporter: A Potential Biological Target from the GABA Transporter Subfamily in Cancer Therapy
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25137339 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Dorota Stary und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Cracow, Poland. Hauptthemen laut MEDLINE: GABA Plasma Membrane Transport Proteins, Molecular Docking Simulation, Membrane Transport Proteins, Molecular Dynamics Simulation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jagiellonian University Medical College, Jagiellonian University, Strategic Program Excellence Initiative at Jagiellonian University.
Abstract (Originalsprache)
The taurine transporter (TauT, SLC6A6) is a member of the solute carrier 6 (SLC6) family, which plays multiple physiological roles. The SLC6 family is divided into four subfamilies: GABA (γ-aminobutyric acid), monoamine, glycine and neutral amino acid transporters. Proteins from the GABA group, including the taurine transporter, are primarily considered therapeutic targets for treating central nervous system disorders. However, recent studies have suggested that inhibitors of SLC6A6 could also serve as anticancer agents. Overexpression of TauT has been associated with the progression of colon and gastric cancer. The pool of known ligands of this transporter is limited and the exact spatial structure of taurine transporter remains unsolved. Understanding its structure could aid in the development of novel inhibitors. Therefore, we utilized homology modelling techniques to create models of TauT. Docking studies and molecular dynamics simulations were conducted to describe protein–ligand interactions. We compared the obtained information for TauT with literature data on other members of the GABA transporter group. Our in silico analysis allowed us to characterize the transporter structure and point out amino acids crucial for ligand binding: Glu406, Gly62 and Tyr138. The significance of selected residues was confirmed through structural studies of mutants. These results will aid in the development of novel taurine transporter inhibitors, which can be explored as anticancer agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Cracow, Poland.
- Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, św. Łazarza 16, 31-530 Cracow, Poland.
ORCID-Profile: Dorota Stary, Marek Bajda
Förderung
- Jagiellonian University Medical College
- Jagiellonian University
- Strategic Program Excellence Initiative at Jagiellonian University
Zitieren
APA
Stary, D., & Bajda, M. (2024). Structural Studies of the Taurine Transporter: A Potential Biological Target from the GABA Transporter Subfamily in Cancer Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137339
Vancouver
Stary D, Bajda M. Structural Studies of the Taurine Transporter: A Potential Biological Target from the GABA Transporter Subfamily in Cancer Therapy. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137339
BibTeX
@article{Stary2024,
author = {Stary, Dorota and Bajda, Marek},
title = {Structural Studies of the Taurine Transporter: A Potential Biological Target from the GABA Transporter Subfamily in Cancer Therapy},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25137339}
}
EUVIMED